Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)- and non-ESBL-producing uropathogenic E. coli

被引：0
|
作者：
Isak Demirel
Annica Kinnunen
Anna Önnberg
Bo Söderquist
Katarina Persson
机构：
[1] Örebro University,Faculty of Medicine and Health
[2] Örebro University Hospital,Department of Laboratory Medicine, Clinical Microbiology
来源：
BMC Microbiology | / 13卷
关键词：
Extended spectrum beta-lactamases; Urinary tract infections; Renal epithelial cells; Polymorphonucleated leukocytes; Uropathogenic ;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Comparison of host response mechanisms evoked by extended spectrum beta lactamase (ESBL)- and non-ESBL-producing uropathogenic E. coli
    Demirel, Isak
    Kinnunen, Annica
    Onnberg, Anna
    Soderquist, Bo
    Persson, Katarina
    [J]. BMC MICROBIOLOGY, 2013, 13
  • [2] Re: Comparison of Host Response Mechanisms Evoked by Extended Spectrum Beta Lactamase (ESBL)-and Non-ESBL-Producing Uropathogenic E. coli Editorial Comment
    Schaeffer, Edward M.
    [J]. JOURNAL OF UROLOGY, 2014, 192 (06): : 1693 - 1693
  • [3] Resistance profiles and genotyping of extended-spectrum beta-lactamase (ESBL) -producing and non-ESBL-producing E. coli and Klebsiella from retail market fishes
    Sajeev, Sudha
    Hamza, Muneeb
    Rajan, Vineeth
    Vijayan, Ardhra
    Sivaraman, Gopalan Krishnan
    Shome, Bibek R.
    Holmes, Mark A.
    [J]. INFECTION GENETICS AND EVOLUTION, 2023, 112
  • [4] Efficacy of Andrographis paniculata against extended spectrum β-lactamase (ESBL) producing E. coli
    Ubaid Rasool
    Priya S
    Afsana Parveen
    Saroj Kumar Sah
    Hemalatha S
    [J]. BMC Complementary and Alternative Medicine, 18
  • [5] Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E-coli compared to non-ESBL producing E-coli
    Melzer, Mark
    Petersen, Irene
    [J]. JOURNAL OF INFECTION, 2007, 55 (03) : 254 - 259
  • [6] Laboratory antimicrobial resistance surveillance: extend spectrum beta lactamase (ESBL) producing E. coli
    S Mobasherizadeh
    S Jalalpoor
    A Ebneshahidi
    L Ghaedi
    [J]. BMC Proceedings, 5 (Suppl 6)
  • [7] The difference in serotypes between extended β-lactamase (ESBL) and non-ESBL-producing E-coli blood culture isolates at a UK district general hospital
    Melzer, M.
    Petersen, I.
    Cheasty, T.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2008, 68 (04) : 367 - 369
  • [8] Cefepime in vitro activity against derepressed extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method
    Naumiuk, L
    Samet, A
    Dziemaszkiewicz, E
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) : 321 - 322
  • [9] Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase (ESBL)-producing versus non-ESBL-producing Escherichia coli in a hollow-fibre infection model
    Islam, Kamrul
    Sime, Fekade B.
    Bauer, Michelle J.
    Forde, Brian M.
    Wallis, Steven C.
    Harris, Patrick
    Naicker, Saiyuri
    Shirin, Tahmina
    Habib, Zakir H.
    Flora, Meerjady S.
    Roberts, Jason A.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (02)
  • [10] Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli
    Handal, Nina
    Whitworth, Jimmy
    Lyngbakken, Magnus Nakrem
    Berdal, Jan Erik
    Dalgard, Olav
    Jorgensen, Silje Bakken
    [J]. INFECTIOUS DISEASES, 2024, 56 (01) : 19 - 31
12345